CBG Faculty

< Back to Index
Axel Schonthal

Axel Schonthal

Associate Professor of Molecular Microbiology & Immunology;Associate Dean for Biomedical Master's Programs
Molecular Microbiology and Immunology
HMR 405A 2011 Zonal Avenue Health Sciences Campus Los Angeles

Contact

+1 323 442 1730
schontha@usc.edu

A perillyl alcohol-conjugated analog of 3-bromopyruvate without cellular uptake dependency on monocarboxylate transporter 1 and with activity in 3-BP-resistant tumor cells Cancer Lett. 2017 08 01; 400:161-174. . View in PubMed

Perillyl Alcohol and Its Drug-Conjugated Derivatives as Potential Novel Methods of Treating Brain Metastases Int J Mol Sci. 2016 Sep 02; 17(9). . View in PubMed

Chemotherapeutic effect of a novel temozolomide analog on nasopharyngeal carcinoma in vitro and in vivo J Biomed Sci. 2015 Aug 19; 22:71. . View in PubMed

A novel temozolomide analog, NEO212, with enhanced activity against MGMT-positive melanoma in vitro and in vivo Cancer Lett. 2015 Mar 28; 358(2):144-151. . View in PubMed

Preclinical development and clinical use of perillyl alcohol for chemoprevention and cancer therapy Am J Cancer Res. 2015; 5(5):1580-93. . View in PubMed

A novel temozolomide-perillyl alcohol conjugate exhibits superior activity against breast cancer cells in vitro and intracranial triple-negative tumor growth in vivo . 2014 May; 13(5):1181-93. . View in PubMed

Pharmacological targeting of endoplasmic reticulum stress signaling in cancer Biochem Pharmacol. 2013 Mar 01; 85(5):653-666. . View in PubMed

Adverse effects of concentrated green tea extracts Mol Nutr Food Res. 2011 Jun; 55(6):874-85. . View in PubMed

The Schonthal lab performs preclinical cancer research and pursues anticancer drug development. The main focus is on brain malignancies, which include primary brain cancers (such as glioblastoma) and secondary brain cancers (such as melanoma or breast cancer that has spread to the brain). The work is done in collaboration with Dr. Thomas Chen, Director of the USC Brain Tumor Group, and Dr. Florence Hofman from the Department of Pathology. This joint approach supports interdisciplinary efforts that translate laboratory findings to patient applications.
Powered by SC CTSI